Agilent and visiopharm expand collaboration with worldwide distribution agreement

Santa clara, calif.--(business wire)--agilent technologies inc. (nyse: a) today announced the signing of a worldwide distribution agreement with visiopharm, enabling agilent to co-market visiopharm's portfolio of ce-ivd marked artificial intelligence (ai)-driven precision pathology software in addition to agilent's portfolio of automated pathology staining solutions. with an initial focus on europe, this agreement marks agilent's first entry into the growing digital pathology market and strengt
A Ratings Summary
A Quant Ranking